Cargando…
Urinary drug metabolite testing in chronic heart failure patients indicates high levels of adherence with life‐prolonging therapies
AIMS: Despite medical therapy for heart failure (HF) having proven benefits of improving quality of life and survival, many patients remain under‐treated. This may be due to a combination of under‐prescription by medical professionals and poor adherence from patients. In HF, as with many other chron...
Autores principales: | Sweeney, Mark, Cole, Graham D., Pabari, Punam, Hadjiphilippou, Savvas, Tayal, Upasana, Mayet, Jamil, Chapman, Neil, Plymen, Carla M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120374/ https://www.ncbi.nlm.nih.gov/pubmed/33709563 http://dx.doi.org/10.1002/ehf2.13284 |
Ejemplares similares
-
The effect of concomitant COVID‐19 infection on outcomes in patients hospitalized with heart failure
por: Chatrath, Nikhil, et al.
Publicado: (2020) -
Smartphone-Based Remote Monitoring in Heart Failure With Reduced Ejection Fraction: Retrospective Cohort Study of Secondary Care Use and Costs
por: Zaman, Sameer, et al.
Publicado: (2023) -
Smartphone-Based Remote Monitoring for Chronic Heart Failure: Mixed Methods Analysis of User Experience From Patient and Nurse Perspectives
por: Auton, Alice, et al.
Publicado: (2023) -
When is an optimization not an optimization? Evaluation of clinical implications of information content (signal-to-noise ratio) in optimization of cardiac resynchronization therapy, and how to measure and maximize it
por: Pabari, Punam A., et al.
Publicado: (2010) -
Artificial Intelligence, Data Sensors and Interconnectivity: Future Opportunities for Heart Failure
por: Bachtiger, Patrik, et al.
Publicado: (2020)